Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0668506
Funder
Australian Research Council
Funding Amount
$150,000.00
Summary
A Multi-Axis Biomaterials Testing Facility. Damage to bones and joints, due to injury or diseases such as osteoporosis and arthritis, is a major cause of disability and cost to the nation. Australia's ageing population contributes not only to an increasing incidence of such conditions, but also to more patients out-living implants such as replacement joints. In 2001-2, Australia spent over $800 million on joint replacement. Because over 11% of procedures are revisions of failed implants, even sm ....A Multi-Axis Biomaterials Testing Facility. Damage to bones and joints, due to injury or diseases such as osteoporosis and arthritis, is a major cause of disability and cost to the nation. Australia's ageing population contributes not only to an increasing incidence of such conditions, but also to more patients out-living implants such as replacement joints. In 2001-2, Australia spent over $800 million on joint replacement. Because over 11% of procedures are revisions of failed implants, even small improvements in implant life represent significant cost savings. By accurately simulating conditions within the body, this biomechanical testing facility will lead to new developments in implant designs and materials, in turn improving quality of life, productivity and treatment costs.Read moreRead less
Vitamin D, Bone Loss, Fracture And Mortality Outcome
Funder
National Health and Medical Research Council
Funding Amount
$408,736.00
Summary
Vitamin D most commonly from sunlight exposure is considered an important determinant of health, including the liability to falls and fractures; not only in the elderly but in adulthood in general. This study aims to distinguish if low vitamin D levels cause adverse health outcomes or relate to ill health, limited sunlight exposure and nutritional change. Only if low vitamin D level is causative of ill health does replacement make good public health sense.
Drug-delivery coating for a new generation of orthopaedic implants. In Australia, the number of people using artificial implants in orthopaedic and dental surgeries is rapidly increasing due to the higher average age of the population and higher expectations for an active and healthy life. The project will enhance the success rate of titanium implants by increasing the strength and stability of tissue at the interface between implant and host, particularly in case of hip joint implants, reducing ....Drug-delivery coating for a new generation of orthopaedic implants. In Australia, the number of people using artificial implants in orthopaedic and dental surgeries is rapidly increasing due to the higher average age of the population and higher expectations for an active and healthy life. The project will enhance the success rate of titanium implants by increasing the strength and stability of tissue at the interface between implant and host, particularly in case of hip joint implants, reducing the need for revision surgery. Read moreRead less
The early osteoarthritis (OA) phenotype. Australia like many other developed countries is undergoing a major demographic shift involving significant growth in the aged population. From both a patient perspective and a societal perspective, research into the underlying determinants of osteoarthritis such as those outlined in this proposal are of great importance to the aged population. Nearly one in five Australians has arthritis; indeed more Australians have arthritis than any other national hea ....The early osteoarthritis (OA) phenotype. Australia like many other developed countries is undergoing a major demographic shift involving significant growth in the aged population. From both a patient perspective and a societal perspective, research into the underlying determinants of osteoarthritis such as those outlined in this proposal are of great importance to the aged population. Nearly one in five Australians has arthritis; indeed more Australians have arthritis than any other national health priority condition. From an individual point-of-view, the pain and disability due to osteoarthritis (OA) can lead to loss of independence and diminished in quality of life for older adults.Read moreRead less
Improving orthopaedic/dental devices by surface chemical modification. The estimated world market for the orthopaedic implants is expected to be US$125 billion by 2010. Australia imports most of it's orthopaedic implants with an estimated cost in excess of AUD300 million by 2010. The current rate of prosthetic failures in orthopaedic patients is unacceptably high. The project aims to develop new implants that integrate better into bone, thus reducing the rate of revision arthroplasty. This would ....Improving orthopaedic/dental devices by surface chemical modification. The estimated world market for the orthopaedic implants is expected to be US$125 billion by 2010. Australia imports most of it's orthopaedic implants with an estimated cost in excess of AUD300 million by 2010. The current rate of prosthetic failures in orthopaedic patients is unacceptably high. The project aims to develop new implants that integrate better into bone, thus reducing the rate of revision arthroplasty. This would lead to a significant reduction in the cost of health care in our aging population and improve the quality of life for prosthetic recipients. Knowledge gained will facilitate the optimization of orthopaedic and implant dentistry, promoting the technology transfer from academia to the relevant medical device industry.Read moreRead less
Development of a Prothrombogenic Bone Graft Substitute. The clinical demand for bone is massive and to counter this bone can be either harvested from the patient or bone substitutes are used. The success or failure of a bone substitute is determined the instant it come into contact with blood. The surfaces of traditional biomaterials induce a foreign body reaction. The aim of this project is to test the bone forming capacity of a biomaterial that is optimised to produce a natural response from ....Development of a Prothrombogenic Bone Graft Substitute. The clinical demand for bone is massive and to counter this bone can be either harvested from the patient or bone substitutes are used. The success or failure of a bone substitute is determined the instant it come into contact with blood. The surfaces of traditional biomaterials induce a foreign body reaction. The aim of this project is to test the bone forming capacity of a biomaterial that is optimised to produce a natural response from the blood. This response will lead to the formation new viable tissue and eventually bone. Such a material will cause faster bone healing, less pain from graft sites, shorter hospital stays and shorter waiting lists. Read moreRead less
Novel Glycoproteomic based diagnostic technology for identifying cartilage tissue turnover and repair. Osteoarthritis is a long-term debilitating disease, which results in the loss of cartilage in the joints, leading to pain and disability. This is a major problem and cost in ageing societies, yet the mechanisms of joint deterioration are still poorly understood. This project will investigate proteoglycans and proteoglycan fragments produced by cells of the joint, detailing the structure of th ....Novel Glycoproteomic based diagnostic technology for identifying cartilage tissue turnover and repair. Osteoarthritis is a long-term debilitating disease, which results in the loss of cartilage in the joints, leading to pain and disability. This is a major problem and cost in ageing societies, yet the mechanisms of joint deterioration are still poorly understood. This project will investigate proteoglycans and proteoglycan fragments produced by cells of the joint, detailing the structure of their sugar components, and map which regions are interacting with antibodies. Understanding these proteoglycan fragments will help us to determine their role in disease progression, and application of this knowledge will assist in the development of an early diagnostic for osteoarthritis.Read moreRead less
Innovative solutions to primary care management of back pain. Each year in Australia over $1billion is spent on low back pain treatment. Part of the reason for this massive expenditure is that back pain is extremely common. Most existing treatments involve highly skilled practitioners and considerable cost to the patient. This program of research will look at evaluating simple, low-cost care for patients with back pain. It will also consider the delivery of back pain care by community pharmacist ....Innovative solutions to primary care management of back pain. Each year in Australia over $1billion is spent on low back pain treatment. Part of the reason for this massive expenditure is that back pain is extremely common. Most existing treatments involve highly skilled practitioners and considerable cost to the patient. This program of research will look at evaluating simple, low-cost care for patients with back pain. It will also consider the delivery of back pain care by community pharmacists, an approach not previously evaluated. Prevention of recurrent back pain will also be studied. Such methods of delivering care will provide enormous savings to the health system while still ensuring best practice care for the patient.Read moreRead less